• SPX
  • $5,969.34
  • 0.35 %
  • $20.63
  • DJI
  • $44,296.51
  • 0.97 %
  • $426.16
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,262.08
  • 1.38 %
  • $112.81
  • IXIC
  • $19,003.65
  • 0.16 %
  • $31.23
TRxADE HEALTH, Inc. (MEDS) Stock Price, News & Analysis

TRxADE HEALTH, Inc. (MEDS) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$7.06
Day's range
$7.7
50-day range
$6.29
Day's range
$10.23
  • Country: US
  • ISIN: US89846A4058
52 wk range
$3.69
Day's range
$44.56
  • CEO: Mr. Surendra K. Ajjarapu
  • Website: Visit Site
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -1.93
  • Piotroski Score 3.00
  • Grade Buy
  • Symbol (MEDS)
  • Company TRxADE HEALTH, Inc.
  • Price $7.59
  • Changes Percentage (4.55%)
  • Change $0.33
  • Day Low $7.06
  • Day High $7.70
  • Year High $44.56

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Land O' Lakes, Florida.

  • Last Earnings 07/08/2024
  • Ex-Dividend for 5/16 Dividend 07/19/2024
  • Dividend Payable 07/24/2024
  • Today N/A
  • Next Earnings (Estimated) 08/08/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$17.96
  • Trailing P/E Ratio -0.36
  • Forward P/E Ratio -0.36
  • P/E Growth -0.36
  • Net Income $-17,843,574

Income Statement

Quarterly

Annual

Latest News of MEDS

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

TRxADE HEALTH, Inc. Frequently Asked Questions

  • What is the TRxADE HEALTH, Inc. stock price today?

    Today's price of TRxADE HEALTH, Inc. is $7.59 — it has increased by +4.55% in the past 24 hours. Watch TRxADE HEALTH, Inc. stock price performance more closely on the chart.

  • Does TRxADE HEALTH, Inc. release reports?

    Yes, you can track TRxADE HEALTH, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the TRxADE HEALTH, Inc. stock forecast?

    Watch the TRxADE HEALTH, Inc. chart and read a more detailed TRxADE HEALTH, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is TRxADE HEALTH, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by TRxADE HEALTH, Inc. stock ticker.

  • How to buy TRxADE HEALTH, Inc. stocks?

    Like other stocks, MEDS shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is TRxADE HEALTH, Inc.'s EBITDA?

    TRxADE HEALTH, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in TRxADE HEALTH, Inc.’s financial statements.

  • What is the TRxADE HEALTH, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -2.1570493703, which equates to approximately -215.70%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in TRxADE HEALTH, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including TRxADE HEALTH, Inc.'s financials relevant news, and technical analysis. TRxADE HEALTH, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for TRxADE HEALTH, Inc. stock currently indicates a “sell” signal. For more insights, review TRxADE HEALTH, Inc.’s technical analysis.

  • A revenue figure for TRxADE HEALTH, Inc. for its last quarter?

    TRxADE HEALTH, Inc. published it's last quarterly revenues at $18,699.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.